Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
873 S-531011, a novel anti-human CCR8 antibody: anti-tumor responses through depletion of tumor-infiltrating CCR8-positive Tregs
Compose a Response to This Article
Other responses
No responses have been published for this article.